Debt-to-equity of Climb Bio, Inc. from 31 Mar 2022 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Climb Bio, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2022 to 31 Dec 2025.
  • Climb Bio, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 3.7%, a 82% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Climb Bio, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 3.7% +1.7% +82% 31 Dec 2025
Q3 2025 3.2% +1.2% +61% 30 Sep 2025
Q2 2025 2.8% +0.5% +22% 30 Jun 2025
Q1 2025 2.3% -0.54% -19% 31 Mar 2025
Q4 2024 2% -1.3% -39% 31 Dec 2024
Q3 2024 2% -1.9% -49% 30 Sep 2024
Q2 2024 2.3% -2.1% -48% 30 Jun 2024
Q1 2024 2.9% -2.1% -42% 31 Mar 2024
Q4 2023 3.3% -1.7% -33% 31 Dec 2023
Q3 2023 3.9% -0.72% -16% 30 Sep 2023
Q2 2023 4.4% +0.25% +5.9% 30 Jun 2023
Q1 2023 5% -0.54% -9.8% 31 Mar 2023
Q4 2022 5% 31 Dec 2022
Q3 2022 4.6% 30 Sep 2022
Q2 2022 4.2% 30 Jun 2022
Q1 2022 5.5% 31 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.